Etiket: Wegovy

The once-a-day Wegovy weight loss pill is now available for purchase in pharmacies across the UK, both on High Street and online. This pill, which contains the same active ingredient—semaglutide—as the popular Wegovy weight loss injections, is not yet covered by the NHS. So, what’s the scoop on this new medication?

First off, both the pill and the injection have proven effective in clinical trials, leading to similar results for those looking to shed some pounds. If you’re not too keen on daily medication or the jab isn’t your thing, this might be a game-changer for you. However, it’s essential to note that the pill is recommended for individuals with a Body Mass Index (BMI) of 30 and above, which is generally classified as obese. Those with a BMI between 27 and 30, who also have certain weight-related health conditions like diabetes or high blood pressure, may also qualify for this treatment. Essentially, the usage criteria mirror those for the injection.

Now, before you rush to grab a bottle, you’ll need to have a consultation—whether that’s online or in-person—to ensure the pill is suitable for you. Many pharmacies are gearing up to stock these pills, with some even suggesting customers sign up for waiting lists to stay in the loop. The semaglutide in both forms mimics a hormone called GLP-1, which your gut releases after eating. This hormone interacts with brain receptors that manage appetite, helping you feel fuller, less hungry, and with fewer cravings.

But let’s not sugarcoat it—side effects are part of the package! Common complaints include stomach issues like nausea, vomiting, constipation, and diarrhea. Those opting for the injection may also notice some skin redness or mild swelling at the injection site. It’s worth mentioning that while most side effects are manageable, there’s a potential for more serious complications like low blood sugar or pancreatitis. So, it’s wise to stay informed and consult health professionals when making this switch.

As for how to take the pill, it’s pretty straightforward. You should swallow it whole with plain water—no fizzy drinks or coffee here! If you miss a dose, just take it the next day; however, don’t double up. The starting dose is 1.5mg once a day for the first month, and after a consultation, you might gradually increase to a maximum of 25mg daily. Keep in mind that it can take a few months to see the full benefits, and there’s always a risk of gaining weight back after stopping the medication.

Prices for the Wegovy pill vary. Some pharmacies are running introductory offers for the first doses, with the lowest dose currently priced around £99 for a month. Keep an eye out, as prices can fluctuate based on dosage and pharmacy. Earlier this month, Wegovy made headlines by becoming the first weight loss pill of its kind cleared by the Medicines and Healthcare products Regulatory Agency (MHRA). However, experts caution that GLP-1 medications aren’t intended for quick fixes or short-term weight loss solutions. They emphasize the importance of a healthy lifestyle, especially when tempting treats are just a stroll down the street away.

So, what’s the takeaway here? Wegovy has officially landed in UK pharmacies, but it’s essential to approach it with the right mindset and under the guidance of healthcare professionals. Will this new option help those struggling with weight loss? Only time will tell…

Kaynak: Orijinal Haber

A pill version of the blockbuster weight-loss drug Wegovy has been approved in the UK, meaning folks will soon be able to snag it with a prescription. This is the first tablet of its kind that has gotten the green light from the Medicines and Healthcare products Regulatory Agency (MHRA). Imagine, no more weekly injections! The manufacturer, Novo Nordisk, claims the once-a-day tablet could be a game changer for many who prefer popping a pill over jabbing themselves with GLP-1 medication that curbs appetite. Plus, these pills don’t even need to be kept in the fridge, which is a nice bonus.

Now, here’s the catch: it won’t be available on the NHS just yet. Experts need to evaluate whether it should be recommended. The National Institute for Health and Care Excellence, the body responsible for making that call, mentioned that Novo Nordisk hasn’t reached out to them yet, but they’re “in active dialogue” with the company. Meanwhile, some high street and online pharmacies are gearing up to add it to their doctor prescribing services in the coming weeks.

According to the MHRA, the starting dose for the tablet is 1.5 mg once daily, which can ramp up to 4 mg, 9 mg, and finally 25 mg, with at least a month spent on each dose level. If you’re currently on the 2.4 mg semaglutide injection weekly, you can switch directly to the 25 mg tablets taken daily. These tablets should be taken on an empty stomach and are already available across the pond in the US. Other companies are either rolling out similar products or working on their own versions.

As for the price? Well, that’s still a bit of a mystery in the UK. But when Wegovy first launched in the US, the starting dose of 1.5 mg was priced at about $149 (around £110) a month. Just like its injection counterpart, the tablets contain semaglutide, which mimics the actions of a natural hormone, GLP-1. This hormone suppresses appetite and slows down digestion, making you feel fuller for longer.

Olivier Picard, the Chair of the National Pharmacy Association, described the approval of the pill as “significant.” He noted that this could really help patients who either can’t or don’t want to take the injectable version. Plus, it might even lower the cost of treatment in the long run. “Pharmacies are waiting for further guidance on when this treatment will be available for patients,” he added.

Trials have shown that these pills are safe and effective. But, just like the injections, it might take a few months to see the full benefits. And there’s always the risk of gaining weight back after stopping the medication. It’s important for anyone taking weight-loss meds to also stick to a healthy diet and get enough exercise. These GLP-1 drugs are not intended for short-term or cosmetic weight loss, and health experts are really pushing back against using them as a quick fix for that “beach body.” Although, let’s be real, some people do misuse them.

Side effects can pop up too, including nausea, diarrhea, constipation, and vomiting. Around a third of UK adults—more than 16 million—struggle with obesity. This new approval could be a big deal for many of them.

Kaynak: Orijinal Haber